News

March 27, 2020

Protocol Deviations Launches New Assets

New! Our Protocol Deviations Initiative just launched a brand new assets page, equipped with a PD Process Guide, PD Map and PD Assessment Plan. To visit the page and explore its materials, click here.

Explore

March 27, 2020

Interpretation of Guidances & Regulation Initiative Publishes New Paper on RSI

To read and download the new paper from our Interpretation of Guidances & Regulations Initiative on the evolving remit of reference safety information, click here.

Explore

March 27, 2020

How do our Member Companies Implement Patient Technology?

Our Patient Technology Initiative asked our Member Companies how they implement PT in clinical trials and shared the findings in a white paper available here.

Explore

March 15, 2020

Industry Experience and Perspective on Clinical Trial Safety Reporting to the FDA

Explore

March 11, 2020

Technology Considerations for enabling eSource in Clinical Research (TIRS)

Explore

March 3, 2020

Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View (TIRS)

Explore

March 1, 2020

PharmaVoice: Bringing the Patient Voice into Clinical Trials

Explore

March 1, 2020

Clinical Leader: Improving Serious Adverse Event (SAE) Reporting In Clinical Trials

Explore

March 1, 2020

SEND harmonization & cross-study analysis: A proposal to better harvest the value from SEND data (Regulatory Toxicology & Pharmacology Journal)

Explore

February 8, 2020

Pharmacovigilance Automation Opportunity – Results from an Industry Survey (Pharmaceutical Medicine)

Explore